Cargando…
Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer
Estrogen receptor–positive breast tumors, which initially respond effectively to endocrine therapy, progress due to acquired endocrine therapy resistance, including genomic alterations in estrogen receptor alpha (ESR1). A recent study has suggested that there is a sufficient number of preexisting ES...
Autores principales: | Kinslow, Connor J, Tang, Ashley, Chaudhary, Kunal R, Cheng, Simon K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438742/ https://www.ncbi.nlm.nih.gov/pubmed/35959983 http://dx.doi.org/10.1093/jncics/pkac060 |
Ejemplares similares
-
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
por: Dahlgren, Malin, et al.
Publicado: (2021) -
Cohesin is required for expression of the estrogen receptor-alpha (ESR1) gene
por: Prenzel, Tanja, et al.
Publicado: (2012) -
Estrogen Receptor Alpha (ESR1)-Dependent Regulation of the Mouse Oviductal Transcriptome
por: Cerny, Katheryn L., et al.
Publicado: (2016) -
Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes.
por: Fjeldheim, F. N., et al.
Publicado: (2016) -
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data
por: Haricharan, Svasti, et al.
Publicado: (2014)